Nava Ltd
NAVANava Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 87th percentile of its own range — the multiple has already done part of the work.
The price is in a confirmed uptrend (16 weeks in) while the P/E sits at the 87th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −55.1% year on year, and 205% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Nava Ltd trades at ₹553, in a confirmed uptrend and 16 weeks into that stage. That is −6.1% against its own 200-day average. It sits at 15% of a 52-week range of ₹522 to ₹727. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (8 weeks and counting).
Today the stock is in a confirmed uptrend — week 16 of stage 2. At ₹553 it trades −6.1% versus its 200-day average and sits at 15% of its 52-week range (₹522–₹727).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,310% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Nava Ltd trades at 20.5× P/E, at the pricey end of its own range (87th percentile). Its long-run median P/E is 6.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 20.5× is at the pricey end of its own range (87th percentile), against a long-run median of 6.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −27.9% against a −10.9% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +54.9%/yr price move, ~+16.8%/yr came from earnings growth and ~+38.1 pp from the multiple (expanding); over 10y, of the +25.2%/yr price move, ~+13.2%/yr came from earnings growth and ~+12.0 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Nava Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −27.5% latest against +53.4% at its 12-quarter best), ROCE slipping at 12.5%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +7.7% | +6.7% | +11.0% | +10.3% |
| Profit | −27.5% | −5.3% | +13.5% | +13.3% |
| EPS | −27.9% | −12.9% | +15.5% | +13.4% |
| Share price | −10.9% | +44.7% | +54.9% | +25.2% |
4-Factor Sector Score
41.7/100 — rank 12 of 20 in Diversified · 89% evidence confidence
Nava Ltd scores 41.7 out of 100 against the 20 companies it is compared with in Diversified, ranking 12. Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
The four contributions add to the total exactly: 9.8 + 14.3 + 13.1 + 4.5 = 41.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Nava Ltd reported ₹1,143 Cr of revenue in the Mar 26 quarter, +12.3% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at 10.3% a year. The last full year, FY26, came in at ₹4,291 Cr. The last four reported quarters add to ₹4,291 Cr.
FY26 revenue came in at ₹4,291 Cr (+7.7% on the year), capping 10 years at 10.3% compound. The latest quarter (Mar 26) printed ₹1,143 Cr, +12.3% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +8.7% growth against the decade's 10.3% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +7.8% over the last 4 quarters against +6.0%/yr over the last 8 — stabilising; TTM profit −27.5% vs −9.0%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Nava Ltd's operating margin is 32.0% in the Mar 26 quarter, −5.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 14.0% to 46.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 32.0%, −5.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 14.0%–46.0%.
🚨 Why the margin moved: operating margin went −5.0 pp year on year while gross margin went +3.7 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Nava Ltd earned ₹136 Cr of net profit in the Mar 26 quarter, −55.1% year on year. Full-year FY26 profit was ₹1,039 Cr. The 10-year compound rate is 13.3%. That is 11.9% of the quarter's revenue. The same quarter a year earlier earned ₹303 Cr.
Mar 26 profit was ₹136 Cr, −55.1% year on year. On the full year, FY26 printed ₹1,039 Cr (−27.5%), and the 10-year compound rate is 13.3%.
🚨 Why profit moved: revenue contributed +12.3% and the margin −5.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −29.9% vs revenue +8.7%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 205% of Nava Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹2,312 Cr of operating cash against ₹1,039 Cr of profit. After ₹2,226 Cr of capital spending, ₹86.0 Cr was left as free cash.
FY26: operating cash of ₹2,312 Cr against reported profit of ₹1,039 Cr, leaving free cash of ₹86.0 Cr after ₹2,226 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 205% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 205%: the cash cycle tightened 103 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 3.1× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Nava Ltd's cash conversion cycle runs 178 days in FY26, down from 281 days in FY21. Capital spending ran ₹3,289 Cr over the last 3 years. At FY26 sales of ₹4,291 Cr each day of that cycle holds about ₹11.8 Cr, so roughly ₹2,093 Cr sits inside the business at any moment.
FY26: debtors at 81 days, inventory at 170 days — roughly 5.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 178 days, tighter than FY21's 281.
The full loop: cash goes out to suppliers and production on day 0; stock waits 170 days to sell; customers pay about 81 days after that; and suppliers themselves are paid at 73 days — netting out to the 178-day cycle.
In money terms: at FY26 sales of ₹4,291 Cr, each day of the cycle holds about ₹11.8 Cr — so the 178-day loop keeps roughly ₹2,093 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹3,289 Cr over the last 3 fiscal years against ₹1,062 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹2,185 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Nava Ltd earns a ROCE of 13% in FY26. That is up from a trough of 2% in FY17. Return on invested capital clears the cost of that capital by −4.8 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 24.2% net margin on 0.30× asset turns.
FY26 ROCE is 13%, recovered from a FY17 trough of 2% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 24.2% net margin × 0.30× asset turns × 1.64× balance-sheet leverage ≈ 11.9% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 7.2% − 12.0% = a −4.8 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Nava Ltd carries total debt of ₹2,226 Cr against shareholder equity of ₹10,764 Cr as of Mar 26, a debt-to-equity of 0.21 — effectively unlevered. On the annual view that ratio went from 0.63 in FY22 to 0.21 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹2,226 Cr against shareholder equity of ₹10,764 Cr — a debt-to-equity of 0.21. On the annual view, debt-to-equity went from 0.63 (FY22) to 0.21 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 1.2 points of Nava Ltd over 8 quarters, the biggest move on the register. That takes promoters to 50.0% of the company. Foreign institutions moved +0.9 points over the same window, to 10.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +1.2 points over 8 quarters to 50.0%; Foreign institutions: +0.9 points over 8 quarters to 10.2%; Domestic institutions: +0.3 points over 8 quarters to 0.6%.
Why the register moved: promoters drove it (+1.2 points), alongside foreign institutions (+0.9 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Nava Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Indiabulls LimitedIBULLSLTD | 61.6/100Mixed-positive evidence67% evidence | LEADER | 18.3/35 Revenue 100% · PAT 100% · OPM change 28 pp 71% evidence | 14.2/25 ROCE 16.2% · OPM 43% 76% evidence | 10.6/20 P/E 13.2× · PEG — 15% evidence | 18.5/20 RS sector 45.4% · RS bench 50.9% · 1Y 82.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 14.2 + 10.6 + 18.5 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2BCL Industries LtdBCLIND | 61.0/100Mixed-positive evidence83% evidence | FADING | 19.3/35 Revenue -0.8% · PAT 21.1% · OPM change 2 pp 83% evidence | 14.4/25 ROCE 13.9% · OPM 9% 95% evidence | 13.1/20 P/E 9.4× · PEG — 50% evidence | 14.2/20 RS sector -0.4% · RS bench 4.6% · 1Y -17.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 14.4 + 13.1 + 14.2 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33M India Ltd3MINDIA | 59.1/100Mixed-positive evidence90% evidence | TURNING | 17.6/35 Revenue 11.5% · PAT -7.5% · OPM change -1.8 pp 88% evidence | 20.0/25 ROCE 40.5% · OPM 17.2% 100% evidence | 11.7/20 P/E 63.8× · PEG 1.25 100% evidence | 9.8/20 RS sector -3.7% · RS bench 3.4% · 1Y 10.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 17.6 + 20 + 11.7 + 9.8 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Grasim Industries LtdGRASIM | 57.6/100Mixed-positive evidence78% evidence | LEADER | 22.9/35 Revenue 18.1% · PAT 32.8% · OPM change 1 pp 83% evidence | 12.8/25 ROCE 8% · OPM 21% 76% evidence | 6.7/20 P/E 42.2× · PEG — 50% evidence | 15.2/20 RS sector 2.2% · RS bench 6.9% · 1Y 14.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 12.8 + 6.7 + 15.2 = 57.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Sobhagya Mercantile Ltd512014 | 56.7/100Mixed-positive evidence71% evidence | ASLEEP | 18.6/35 Revenue 49.3% · PAT 41.8% · OPM change -3.7 pp 83% evidence | 18.5/25 ROCE 23.4% · OPM 10.9% 76% evidence | 9.7/20 P/E 43.3× · PEG — 15% evidence | 9.9/20 RS sector -1% · RS bench 3.7% · 1Y 62.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 18.5 + 9.7 + 9.9 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Texmaco Infrastructure & Holdings LtdTEXINFRA | 55.9/100Mixed-positive evidence76% evidence | LEADER | 24.3/35 Revenue 9.9% · PAT 100% · OPM change 78.8 pp 83% evidence | 5.5/25 ROCE 1.4% · OPM -41.9% 95% evidence | 8.7/20 P/E 133× · PEG — 15% evidence | 17.4/20 RS sector 7.9% · RS bench 12.9% · 1Y 15.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 5.5 + 8.7 + 17.4 = 55.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Kalind Ltd526935 | 55.2/100Mixed-positive evidence67% evidence | BASING | 23.6/35 Revenue — · PAT — · OPM change 21 pp 52% evidence | 18.2/25 ROCE 32% · OPM 63% 76% evidence | 10.6/20 P/E 21.8× · PEG — 50% evidence | 2.8/20 RS sector -84.1% · RS bench 2% · 1Y -44.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 18.2 + 10.6 + 2.8 = 55.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -84.1% and the one-year return is -44.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Balmer Lawrie & Company LtdBALMLAWRIE | 53.8/100Mixed-positive evidence82% evidence | ASLEEP | 16.6/35 Revenue 8.9% · PAT 3.8% · OPM change 1 pp 95% evidence | 15.3/25 ROCE 14.6% · OPM 13% 76% evidence | 14.5/20 P/E 10.6× · PEG — 50% evidence | 7.4/20 RS sector -13.8% · RS bench -9.4% · 1Y -20.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 15.3 + 14.5 + 7.4 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tube Investments of India LtdTIINDIA | 46.1/100Mixed-negative evidence96% evidence | ASLEEP | 18.6/35 Revenue 17.4% · PAT 6.1% · OPM change 2 pp 88% evidence | 17.9/25 ROCE 17.1% · OPM 9% 100% evidence | 2.0/20 P/E 80.6× · PEG 9.63 100% evidence | 7.6/20 RS sector -9.1% · RS bench -4.8% · 1Y -4.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 17.9 + 2 + 7.6 = 46.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 10Nurture Well Industries Ltd531889 | 45.0/100Mixed-negative evidence71% evidence | ASLEEP | 15.8/35 Revenue 34% · PAT 27% · OPM change -9.1 pp 83% evidence | 15.0/25 ROCE 22.9% · OPM 0.2% 76% evidence | 11.5/20 P/E 8.6× · PEG — 15% evidence | 2.7/20 RS sector -21.8% · RS bench -18.1% · 1Y 23.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 15 + 11.5 + 2.7 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Bluspring Enterprises LtdBLUSPRING | 43.0/100Thin evidence · provisional57% evidence | TURNING | 18.4/35 Revenue 11.8% · PAT 90.6% · OPM change 0.7 pp 71% evidence | 3.5/25 ROCE 5.1% · OPM 2.2% 95% evidence | 8.9/20 P/E 114× · PEG — 15% evidence | 12.2/20 RS sector — · RS bench 51.5% · 1Y 23.7%10 of 10 weeks ahead 25% evidence |
| Exact sum: 18.4 + 3.5 + 8.9 + 12.2 = 43 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Nava Ltdthis pageNAVA | 41.7/100Mixed-negative evidence89% evidence | ASLEEP | 9.8/35 Revenue 7.8% · PAT -27.6% · OPM change -5 pp 88% evidence | 14.3/25 ROCE 12.8% · OPM 32% 100% evidence | 13.1/20 P/E 20.5× · PEG 1.16 65% evidence | 4.5/20 RS sector -13.4% · RS bench -9.3% · 1Y -9.6%3 of 12 weeks ahead 100% evidence |
| Exact sum: 9.8 + 14.3 + 13.1 + 4.5 = 41.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Swan Corp LtdSWANCORP | 35.8/100Thin evidence · provisional58% evidence | ASLEEP | 15.1/35 Revenue -11.5% · PAT -69% · OPM change -31.6 pp 62% evidence | 6.3/25 ROCE 3.9% · OPM -30% 76% evidence | 10.1/20 P/E 35.2× · PEG — 15% evidence | 4.3/20 RS sector -29.3% · RS bench -22.8% · 1Y -35%0 of 10 weeks ahead 70% evidence |
| Exact sum: 15.1 + 6.3 + 10.1 + 4.3 = 35.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Andrew Yule & Company LtdANDREWYU | 34.7/100Thin evidence · provisional55% evidence | TURNING | 13.2/35 Revenue -4.8% · PAT -80% · OPM change -9 pp 62% evidence | 3.5/25 ROCE -6.3% · OPM -52% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.0/20 RS sector -37% · RS bench 13.8% · 1Y -5.2%10 of 11 weeks ahead 70% evidence |
| Exact sum: 13.2 + 3.5 + 10 + 8 = 34.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Integrated Industries LtdIIL | 64.5/100Thin evidence · provisional50% evidence | 20.6/35 Revenue 60.5% · PAT 94.6% · OPM change 2 pp 53% evidence | 16.7/25 ROCE 30.5% · OPM 11% 57% evidence | 11.0/20 P/E 11.6× · PEG — 15% evidence | 16.2/20 RS sector 51.9% · RS bench 63.7% · 1Y 114.3%11 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 20.6 + 16.7 + 11 + 16.2 = 64.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Arunis Abode LtdARUNIS | 50.8/100Thin evidence · provisional45% evidence | 15.3/35 Revenue 100% · PAT 100% · OPM change -17.7 pp 40% evidence | 9.4/25 ROCE -5.3% · OPM 28.5% 57% evidence | 9.4/20 P/E 62.5× · PEG — 15% evidence | 16.7/20 RS sector 131.3% · RS bench 136.7% · 1Y 395.6%12 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.3 + 9.4 + 9.4 + 16.7 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Piramal Enterprises Ltd(Merged)PEL | 47.8/100Thin evidence · provisional41% evidence | 19.0/35 Revenue 13.3% · PAT 100% · OPM change -0.7 pp 27% evidence | 11.8/25 ROCE 6.8% · OPM 65.1% 57% evidence | 9.6/20 P/E 49× · PEG — 15% evidence | 7.4/20 RS sector -20.3% · RS bench 1% · 1Y -12.1%6 of 12 weeks ahead to 2025-09-24 70% evidence | |
| Exact sum: 19 + 11.8 + 9.6 + 7.4 = 47.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Bharat Global Developers LtdBGDL | 46.9/100Thin evidence · provisional47% evidence | 15.6/35 Revenue -74% · PAT -80% · OPM change 4.2 pp 53% evidence | 10.8/25 ROCE 11.3% · OPM — 46% evidence | 8.5/20 P/E 291× · PEG — 15% evidence | 12.0/20 RS sector 165.8% · RS bench -70.1% · 1Y -17.1%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.6 + 10.8 + 8.5 + 12 = 46.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Rossell India LtdROSSELLIND | 41.1/100Thin evidence · provisional47% evidence | 14.5/35 Revenue 4.8% · PAT -41.1% · OPM change 0.1 pp 36% evidence | 11.0/25 ROCE 6.4% · OPM 10.7% 71% evidence | 10.8/20 P/E 11.8× · PEG — 15% evidence | 4.8/20 RS sector -28.8% · RS bench -19.6% · 1Y -35%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 14.5 + 11 + 10.8 + 4.8 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Kesar Enterprises LtdKESAR | 33.6/100Thin evidence · provisional42% evidence | 14.2/35 Revenue -55.3% · PAT -80% · OPM change 7.4 pp 40% evidence | 5.9/25 ROCE -26.2% · OPM 2.8% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -44.4% · RS bench -39.4% · 1Y -66.4%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 14.2 + 5.9 + 10 + 3.5 = 33.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Nava Ltd's share price today?
Nava Ltd trades at ₹553, −10.9% over the past year. The company is valued at ₹15,677 Cr. The stock sits at 15% of its 52-week range of ₹522–₹727, −6.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 16 weeks in. — as of 31 July 2026.
What were Nava Ltd's latest quarterly results?
Nava Ltd reported revenue of ₹1,143 Cr and net profit of ₹136 Cr for the Mar 26 quarter. Revenue rose 12.3% and profit fell 55.1% year on year. Earnings per share were ₹4.49. The operating margin was 32.0%, 5.0 pp lower than a year earlier. — as of 31 July 2026.
What is Nava Ltd's revenue?
Nava Ltd reported revenue of ₹1,143 Cr in the Mar 26 quarter, +12.3% year on year. For the full FY26 fiscal year, revenue was ₹4,291 Cr (+7.7%). Over the last 10 years revenue compounded at 10.3% a year. — as of 31 July 2026.
What is Nava Ltd's profit?
Nava Ltd earned ₹136 Cr of net profit in the Mar 26 quarter, −55.1% year on year. Full-year FY26 profit was ₹1,039 Cr. The operating margin ran 32.0% in the latest quarter. — as of 31 July 2026.
What is Nava Ltd's market cap?
Nava Ltd's market capitalisation is ₹15,677 Cr at a share price of ₹553. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Nava Ltd's P/E ratio?
Nava Ltd trades at a P/E of 20.5×, at the 87th percentile of its own 10-year range, against a long-run median of 6.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Nava Ltd pay a dividend?
Yes — Nava Ltd's dividend payout was 31% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Nava Ltd overvalued?
On its own history, Nava Ltd looks expensive against its own history: its P/E of 20.5× sits at the 87th percentile of its 10-year range (long-run median 6.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Nava Ltd growing?
Not right now — Nava Ltd's latest numbers are shrinking: latest-quarter revenue +12.3% year on year, profit −55.1%, and the margin −5.0 pp at 32.0%. The 10-year compound rates are 10.3% (revenue) and 13.3% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Nava Ltd performing?
Nava Ltd is in a confirmed uptrend, 16 weeks in. Its latest quarter's revenue rose 12.3% and profit fell 55.1% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Nava Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −27.5% latest against +53.4% at its 12-quarter best), ROCE slipping at 12.5%. The read comes from the last 12 quarters of growth (revenue growth +7.8% latest, profit growth −27.5% latest, eps growth −26.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Nava Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 16 of stage 2), trading −6.1% versus its 200-day average and at 15% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Nava Ltd beating the market?
Not lately — on a trailing-13-week view Nava Ltd is currently behind the NIFTY 500 (8 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,310% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 31 July 2026.
Will Nava Ltd's share price go up?
This page publishes no price forecast for Nava Ltd. What it measures instead: the share price is ₹553, the price is in a confirmed uptrend 16 weeks in. Its P/E of 20.5× sits at the 87th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Nava Ltd?
Promoters hold 50.0% of Nava Ltd, foreign institutions 10.2%, domestic institutions 0.6% and the public 39.2% (latest quarter). The biggest move on the register over the last two years: Promoters added 1.2 points over 8 quarters. — as of 31 July 2026.
Does Nava Ltd have too much debt?
No — Nava Ltd's debt-to-equity is 0.25, and operating profit covers the interest bill north of 100×. FY26 borrowings were ₹2,226 Cr against equity of ₹8,745 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Nava Ltd's capex?
Nava Ltd spent ₹3,289 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹2,226 Cr, with ₹2,185 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Nava Ltd's cash flow?
Nava Ltd generated ₹2,312 Cr of operating cash flow in FY26 and ₹86.0 Cr of free cash flow after ₹2,226 Cr of capital spending. Reported profit that year was ₹1,039 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Nava Ltd's profit real cash?
Yes — over the last 3 fiscal years, 205% of Nava Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹2,312 Cr against reported profit of ₹1,039 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Nava Ltd in its business cycle?
Nava Ltd's FY26 operating margin was 40.0%, against a 13-year band of 14.0%–46.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 32.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Nava Ltd story?
Biggest watch item: the P/E sits at the 87th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Nava Ltd a stock worth studying right now?
This is not investment advice. The machine read: Nava Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.